IDEAYA Biosciences Income Statement (2019-2025) | IDYA

Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 8.97M10.57M7.25M8.76M8.98M2.96M11.36M5.85M29.70M4.02M7.88M3.54M8.04M3.92M7.00M207.83M
Operating items
Research & Development 10.03M12.05M11.57M14.98M15.50M16.11M19.66M22.80M22.37M24.71M27.86M29.18M33.70M38.77M42.80M54.53M57.15M140.18M82.99M
Selling, General & Administrative 3.94M3.80M4.82M4.83M5.19M5.22M5.92M5.55M6.67M5.75M6.30M7.08M7.86M7.07M8.21M10.39M9.74M10.96M16.39M
Operating Expenses 13.96M15.85M16.38M19.81M20.69M21.33M25.58M28.35M29.04M30.46M34.16M36.25M41.56M45.84M51.02M64.93M66.89M151.14M99.38M
Operating Income -5.00M-5.28M-9.13M-11.05M-11.71M-18.37M-14.22M-22.50M0.66M-26.44M-26.28M-32.71M-33.53M-41.92M-51.02M-64.93M-66.89M-144.14M108.45M
EBIT -5.00M-5.28M-9.13M-11.05M-11.71M-18.37M-14.22M-22.50M0.66M-26.44M-26.28M-32.71M-33.53M-41.92M-51.02M-64.93M-66.89M-144.14M108.45M
Non-operating items
Non Operating Income 0.07M0.14M0.11M0.10M0.13M0.16M0.21M0.44M0.95M2.24M2.64M4.78M6.09M7.96M11.45M12.15M15.07M13.83M10.79M
Net income details
EBT -5.00M-5.28M-9.13M-11.05M-11.71M-18.37M-14.22M-22.50M0.66M-26.44M-26.28M-32.71M-33.53M-41.92M-51.02M-64.93M-66.89M-144.14M108.45M
Profit After Tax -4.93M-5.13M-9.02M-10.95M-11.58M-18.21M-14.01M-22.06M1.61M-24.20M-23.64M-27.93M-27.44M-33.95M-39.57M-52.77M-51.82M-130.31M119.24M
Income from Continuing Operations -5.00M-5.28M-9.13M-11.05M-11.71M-18.37M-14.22M-22.50M0.66M-26.44M-26.28M-32.71M-33.53M-41.92M-51.02M-64.93M-66.89M-144.14M108.45M
Consolidated Net Income -5.00M-5.28M-9.13M-11.05M-11.71M-18.37M-14.22M-22.50M0.66M-26.44M-26.28M-32.71M-33.53M-41.92M-51.02M-64.93M-66.89M-144.14M108.45M
Income towards Parent Company -5.00M-5.28M-9.13M-11.05M-11.71M-18.37M-14.22M-22.50M0.66M-26.44M-26.28M-32.71M-33.53M-41.92M-51.02M-64.93M-66.89M-144.14M108.45M
Net Income towards Common Stockholders -5.00M-5.28M-9.13M-11.05M-11.71M-18.37M-14.22M-22.50M0.66M-26.44M-26.28M-32.71M-33.53M-41.92M-51.02M-64.93M-66.89M-144.14M108.45M
Additional items
EPS (Basic) -0.17-0.14-0.28-0.33-0.31-0.49-0.36-0.570.04-0.54-0.49-0.50-0.46-0.52-0.53-0.68-0.60-1.551.35
EPS (Weighted Average and Diluted) -0.29-0.31-0.49-0.36-0.570.04-0.54-0.49-0.50-0.46-0.52-0.53-0.68-0.60-1.551.33
Shares Outstanding (Weighted Average) 19.48M20.31M20.33M20.34M20.40M29.03M29.07M32.26M32.91M38.40M38.50M38.63M38.64M39.31M48.11M48.39M57.29M57.56M64.46M74.56M75.69M84.48M86.43M87.54M87.58M87.64M
Shares Outstanding (Diluted Average) 35.25M41.11M41.44M48.37M56.25M60.00M57.52M75.11M77.96M86.19M81.68M88.36M88.47M
EBITDA -4.95M-5.16M-9.03M-10.95M-11.63M-18.87M-16.11M-22.88M1.24M-23.07M-22.17M-27.70M-27.01M-32.64M-41.06M-53.27M-46.57M-133.34M119.78M